Israel (TASE:ILCO) Looks Cheap Following A 31% One Year Slide

With no single event driving headlines today, Israel (TASE:ILCO) is getting attention after a difficult run for shareholders, including a decline of about 16% over the past month and a 31% drop over the past year.

At a share price of ₪74.99, Israel has seen short-term momentum fade, with a 30-day share price return down 16.24%, while the 1-year total shareholder return down 30.72% points to pressure that extends beyond the recent pullback.

Scan beyond Israel's recent share price slide and review a curated 182 high quality undervalued stocks that currently pairs pressured valuations with solid fundamentals.

For Israel, a 31% slide in a year can signal cracks in the business or simply sentiment swinging too far. The next step is to see which story the current valuation supports.

Preferred P/E of 14.9x: Is it justified?

Israel now trades on a P/E of 14.9x at a share price of ₪74.99, which lines up below peer valuations and suggests the market is assigning a lower earnings multiple than many investors in the sector have been willing to pay elsewhere.

The P/E ratio compares what you pay for each ₪1 of earnings. For a diversified chemicals and specialty minerals group like Israel, this yardstick helps you see how the market prices its profit stream relative to other producers that face similar capital intensity, commodity exposure and regulatory demands.

On this measure, Israel screens as cheaper than broad peer groups. The P/E of 14.9x sits under the Asian chemicals average of 20.4x and well below the narrower peer group at 34.8x. This signals that investors are currently assigning a clear discount to Israel's earnings compared with both its regional industry and closer comparables.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-earnings of 14.9x (UNDERVALUED)

Still, Israel relies heavily on cyclical fertilizer and industrial minerals demand, so weaker agricultural spending or softer commodity pricing could quickly challenge the current valuation story.

Find out about the key risks to this Israel narrative.

Another view on Israel's value

The DCF output tells a very different story. Israel trades at ₪74.99 while our DCF model points to a future cash flow value of ₪11.80, which frames the shares as richly priced rather than cheap on earnings. That raises a simple question: Which signal should an investor trust?

For a closer look at how this cash flow estimate is built, review the full SWS DCF breakdown for Israel, including the underlying assumptions and sensitivities, in the Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Israel for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 182 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Sentiment around Israel looks conflicted, with pressure on the share price but some underlying positives still in view, so move quickly and test the data for yourself by weighing the 1 key reward and 1 important warning sign

Looking for more investment ideas beyond Israel?

Do not stop your research with Israel alone. Fresh opportunities often sit where pricing, quality and risk come together in ways the headlines are not covering.

• Target potential mispricing by scanning a curated pool of pressured yet financially sound candidates through the 182 high quality undervalued stocks.
• Prioritise resilience by focusing on companies with strong financial footing using the list of solid balance sheet and fundamentals (207 results).
• Hunt for under-the-radar opportunities with robust fundamentals inside the 619 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com